Brian Mullan is the chief technical officer of Yposkesi, an SK Pharmteco company.
Choosing the Right CDMO for CGT Programs
Whether biologic manufacturers decide to outsource or develop products internally, the quality of a CDMO partnership is critical to success, especially for cell and gene therapy products.